More generic alternatives

Israel’s Teva has launched generic versions of the anti-nausea treatment ALOXI and Lialda delayed-release mesalamine.  It is good news for cancer patients receiving chemotherapy and ulcerative colitis sufferers respectively.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *